Pediatrix Medical Group, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pediatrix Medical Group, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q4 2024.
  • Pediatrix Medical Group, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $2.85M.
  • Pediatrix Medical Group, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$2.27M, a 119% decline year-over-year.
  • Pediatrix Medical Group, Inc. annual Income Tax Expense (Benefit) for 2024 was -$2.27M, a 119% decline from 2023.
  • Pediatrix Medical Group, Inc. annual Income Tax Expense (Benefit) for 2023 was $12M, a 35.9% decline from 2022.
  • Pediatrix Medical Group, Inc. annual Income Tax Expense (Benefit) for 2022 was $18.8M, a 31% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$2.27M $2.85M +$17.4M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-20
Q3 2024 -$19.7M $5.79M -$3.65M -38.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 -$16M -$14.7M -$25.4M -238% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $9.33M $3.79M -$2.72M -41.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $12M -$14.6M -$18.4M -481% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-20
Q3 2023 $30.4M $9.44M -$610K -6.07% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 $31M $10.7M -$1.67M -13.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $32.7M $6.51M +$13.9M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $18.8M $3.82M -$9.42M -71.1% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-20
Q3 2022 $28.2M $10.1M -$1.54M -13.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $29.8M $12.3M +$4.97M +67.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $24.8M -$7.4M -$2.45M -49.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $27.2M $13.2M +$7.37M +126% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $19.9M $11.6M +$4.92M +73.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $15M $7.36M +$4.27M +138% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $10.7M -$4.96M -$6.04M -557% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $16.7M $5.87M +$1.88M +47.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-18
Q3 2020 $14.8M $6.68M -$683K -9.28% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $15.5M $3.1M -$3.65M -54.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $19.2M $1.09M +$2.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $16.6M $3.99M -$17.7M -81.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-18
Q3 2019 $34.3M $7.36M -$16.2M -68.7% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-18
Q2 2019 $50.5M $6.74M -$21.7M -76.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-18
Q1 2019 $72.2M -$1.51M -$24.2M -107% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-18
Q4 2018 $96.5M $21.7M +$49.5M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 $47M $23.6M -$18.6M -44.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-20
Q2 2018 $65.6M $28.5M -$12.2M -30.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-20
Q1 2018 $77.8M $22.7M -$12.2M -35% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-20
Q4 2017 $90.1M -$27.8M -$77.7M -156% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-14
Q3 2017 $168M $42.1M -$2.15M -4.86% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-14
Q2 2017 $170M $40.7M -$10.9M -21.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-14
Q1 2017 $181M $35M -$8.44M -19.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-14
Q4 2016 $189M $49.9M -$1.66M -3.22% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-14
Q3 2016 $191M $44.3M -$11.4M -20.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-14
Q2 2016 $202M $51.6M -$1.29M -2.44% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-14
Q1 2016 $204M $43.4M -$517K -1.18% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-14
Q4 2015 $204M $51.6M +$987K +1.95% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-10
Q3 2015 $203M $55.6M +$4.47M +8.73% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-10
Q2 2015 $199M $52.9M +$3.95M +8.06% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-10
Q1 2015 $195M $43.9M +$3.23M +7.93% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-10
Q4 2014 $191M $50.6M +$6.17M +13.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-11
Q3 2014 $185M $51.2M +$5.98M +13.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-11
Q2 2014 $179M $48.9M +$6.07M +14.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-11
Q1 2014 $173M $40.7M +$5.3M +15% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-11
Q4 2013 $168M $44.4M +$8.04M +22.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-09
Q3 2013 $160M $45.2M +$3.94M +9.54% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-09
Q2 2013 $156M $42.9M +$4.17M +10.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-09
Q1 2013 $152M $35.4M +$4.49M +14.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-09
Q4 2012 $147M $36.4M +$3.41M +10.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-12
Q3 2012 $144M $41.3M +$5.18M +14.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-12
Q2 2012 $139M $38.7M +$2.19M +5.99% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-12
Q1 2012 $136M $30.9M +$1.23M +4.16% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-12
Q4 2011 $135M $33M +$1.44M +4.57% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-15
Q3 2011 $134M $36.1M +$16M +79.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-15
Q2 2011 $118M $36.5M +$4.63M +14.5% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-15
Q1 2011 $113M $29.7M +$4.7M +18.8% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-15
Q4 2010 $108M $31.5M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $20.1M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $31.9M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $25M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.